18F-Flutemetamol and Plaque Vulnerability
NCT03291093
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Atherosclerosis
Interventions
DRUG:
18F-Flutemetamol PET/MRI
Sponsor
Maastricht University Medical Center